Eledon Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Eledon Pharmaceuticals

12/11/2024 23:31

* Eledon Pharmaceuticals Inc  ELDN.OQ  reported a quarterly
adjusted loss of 32 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -35 cents.  The mean expectation of
five analysts for the quarter was for a loss of 31 cents per
share. Wall Street expected results to range from -37 cents
to -20 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Eledon Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 32 cents​.
    * The company reported a quarterly loss of $17.5 million.
    * Eledon Pharmaceuticals Inc shares had risen by 99.2% this
quarter and gained 175.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 14.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $10.00 
This summary was machine generated from LSEG data November 12 at
11:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.31          -0.32          Missed
 Jun. 30 2024      -0.30          -1.06          Missed
 Mar. 31 2024      -0.37          -0.34          Beat
 Dec. 31 2023      -0.39          -0.29          Beat